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Abstract	
Hepatic artery stenosis (HAS) remains a rare but serious complication after liver transplantation.
While invasive surgical techniques were needed for HAS treatment in the past, recently endovascular
techniques, including hepatic artery stenting, have been proven to be a safe and effective treatment.
The present work focused on a review of the recent literature regarding HAS as well as recent cases
demonstrating the various presentations of HAS and the variety of approaches to endovascular
intervention. Our single-center experience has shown endovascular treatment of HAS to be safe
and effective, including the two specific cases discussed here. While further research is needed,
endovascular stenting as a treatment for HAS appears to be a promising, minimally invasive technique
to help aid in the long-term health of post-liver transplant patients.
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The hepatic artery provides blood flow to both the liver
parenchyma and the biliary system and inadequate
perfusion may have significant consequences.
Hepatic artery stenosis (HAS) is a rare but important
complication of orthotopic liver transplantation. The
traditional treatment modality formerly consisted
of open surgical techniques such as revision of the
anastomotic site or placement of a bypass graft.1 More
recently, however, endovascular techniques have shown
to be effective.2,3 Herein we review the effectiveness of
using traditional coronary artery-based techniques and
equipment to treat stenosis of two different abdominal
arteries.

CASE DESCRIPTIONS

Case #1 –– Clinical History
A 56-year-old woman with a history of autoimmune
hepatitis and resultant liver cirrhosis post-orthotopic
liver transplant (Model for End-Stage Liver Disease
[MELD] score of 28 at time of transplantation)
was found on routine laboratory surveillance to
have elevated liver enzymes, with an aspartate
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aminotransferase of 102, alanine aminotransferase
of 155 and alkaline phosphatase of 307. Her liver
transplantation was performed 11 months prior and
was complicated by postoperative acute hepatic artery
thrombosis requiring surgical thrombectomy. As part
of her workup, she had Doppler ultrasound of the
liver, which came out suspect for HAS and therefore
further diagnostic imaging was recommended. She
was referred to cardiology, where a hepatic artery
angiogram was performed and confirmed HAS.
Procedure
The left brachial artery was cannulated using a
4-French micropuncture kit and modified Seldinger
technique. A 5-French 11-cm sheath was advanced
into the artery. Using a 5-French pigtail catheter and
J-wire, we obtained access to the descending aorta.
The J-wire was removed and a 0.035-inch wire (Supra
Core, Abbott Vascular, Abbott Park, IL) was left in the
descending aorta. The pigtail catheter and the 5-French
sheath were removed and a 6-French 55-cm sheath
(Ansel, Cook Medical Inc., Bloomington, IN) was
advanced to the abdominal aorta over the Supra Core
wire. A 6-French multipurpose guide catheter was
then used to selectively engage the celiac trunk and
multiple angiographic images obtained. The patient
was noted to have a 70–80% stenosis of hepatic artery
www.aurora.org/jpcrr

Review

127

Figure 1. Angiograms of a 56-year-old woman with hepatic artery stenosis after liver transplantation. A: The patient

developed a 70–80% stenosis at the anastamotic site. B: The lesion was stented with a 4.0 × 30-mm drug-eluting
coronary stent. C: The artery was widely patent after stenting and nitroglycerin administration, with no significant
residual stenosis.

at the anastomotic site (Figure 1A). The images were
reviewed with the transplant surgeon and the decision
was made to proceed with direct stenting of the lesion.
The patient was given a weight-based bolus of heparin
for anticoagulation to keep the activated clotting time
(ACT) > 250 ms. Next, a 0.014-inch wire (Balance
Middleweight, Abbott Vascular) was advanced past
the hepatic anastomotic site and secured distally. Prior
to stenting, balloon angioplasty was performed with
a 3.0 × 20-mm balloon (Trek, Abbott Vascular) at 2
atmospheres for 11 seconds, then at 8 atmospheres for
18 seconds. Percutaneous transluminal angioplasty
(PTA) and stenting was performed with a 4.0 × 30mm drug-eluting stent (Resolute Integrity, Medtronic
Inc., Minneapolis, MN) with stent deployment at 9
atmospheres for 6 seconds (Figure 1B). Poststent
angiogram revealed a vasospasm, which was relieved
with intrahepatic artery nitroglycerin (Figure 1C).
The patient tolerated the procedure well without
complications. She was transferred to the coronary
intensive care unit in a hemodynamically stable
condition.
Postprocedure Condition
Liver enzymes obtained 1 week postprocedure had
improved to aspartate aminotransferase of 66, alanine
aminotransferase of 104 and alkaline phosphatase of
242.
Case #2 –– Clinical History
A 77-year-old woman with history of primary biliary
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cirrhosis and metastatic hepatocellular carcinoma
who underwent previous transcatheter arterial
chemoembolization procedures was evaluated the
day after orthotopic liver transplant (MELD score of
29 at time of transplantation). A Doppler ultrasound
identified suspicious decreased flow velocity indices
in the hepatic arteries and its branches as well as a
heterogenous 11.1 × 4.9 × 7.5-mm fluid collection
in Morrison’s pouch. Computed tomographic (CT)
angiogram revealed a short segment occlusion of the
proximal celiac artery with a possible focal dissection.
Normal flow was seen in the remainder of the celiac
and hepatic arteries. Thus, a celiac artery angiogram
was recommended.
Procedure
The right femoral artery was cannulated using a
4-French micropuncture kit and modified Seldinger
technique. A 5-French 11-cm sheath was advanced into
the right common femoral artery. A 5-French pigtail
catheter was then advanced into the abdominal aorta
and a nonselective mesenteric angiogram performed
using a power injector (Figure 2A). A dissection within
the proximal celiac trunk with 100% occlusion was
identified (Figure 2B). Due to the acute takeoff of the
celiac trunk, the decision was made to proceed with
intervention via a left brachial artery approach. The
left brachial artery was cannulated using a 4-French
micropuncture kit and modified Seldinger technique.
A 5-French 11-cm sheath was advanced into the artery.
The 5-French pigtail catheter and J-wire were used to
Review

obtain access to the descending aorta. The J-wire was
removed and a 0.035-inch Supra Core wire advanced
into the descending aorta. Both the 5-French pigtail
catheter and 11-cm sheath were then removed. Next,
a 6-French 55-cm Ansel sheath was advanced over the
Supra Core wire into the descending abdominal aorta.
A 6-French multipurpose guide catheter was then used
to selectively engage the celiac trunk. The patient was
given a weight-based bolus of heparin to keep the
ACT > 250. Next, a 0.014-inch wire (Whisper, Abbott
Vascular) was advanced past the celiac occlusion
and secured in the splenic artery. Predilation was
performed to the multiple segments of the celiac
trunk with a 2.0 × 15-mm balloon (Mini-Trek, Abbott
Vascular) at 12 atmospheres for 4 seconds, 9 seconds
and 6 seconds. Further predilation was performed in
multiple segments of the celiac trunk with a larger 4.0
× 20-mm Trek balloon at 8 atmospheres for 16 seconds
and 6 seconds. Subsequent angiogram revealed that
a large dissection flap was still visible, thus PTA and
stenting was performed to the celiac artery with a 4.0
× 22-mm Resolute Integrity drug-eluting stent at 9
atmospheres for 11 seconds. A second 4.0 × 18-mm
Resolute Integrity drug-eluting stent was deployed at
16 atmospheres for 8 seconds inside the first stent to
add radial strength (Figure 2C).
Postprocedure Condition
Final angiogram revealed excellent Thrombolysis in
Myocardial Infarction (TIMI) grade 3 flow throughout
the celiac trunk and its downstream branches (Figure
2D).

DISCUSSION

The incidence of hepatic artery stenosis after orthotopic
liver transplantation is reported to be approximately
5–13%.4 It most commonly occurs at the anastomotic
site between the native and transplanted hepatic
arteries. The most common etiologies are thought to
be related to operative technique or due to cross-clamp
injury. Less frequently, it is associated with allograft
rejection, microvascular injury associated with cold
preservation injury, or extrinsic compression.2,5 Patients
who develop HAS postoperatively have approximately
a 65% chance of developing hepatic artery thrombosis,
which can be a devastating complication leading to
severe biliary damage, acute liver dysfunction and,
ultimately, allograft failure.3 In addition to HAS, other
Review

Figure 2. Angiograms of a 77-year-old woman found

to have occlusion of celiac artery after liver transplantation. A: Aortogram revealing occlusion of proximal
celiac artery. B: Selective angiogram of celiac artery
with appearance suggestive of flow-limiting dissection.
C: Access to true lumen was obtained, and lesion was
stented with 4.0 × 22-mm and 4.0 × 18-mm drug-eluting
stents. D: Final angiogram showing patent celiac and
hepatic artery.

vascular complications that should be assessed include
hepatic artery kinking related to excessive vessel
length, pseudoaneurysm and arterial dissection.
HAS has been reported to occur most often within
the first year after transplantation, with a mean
ranging from 100 to 126 days.3 Patients may present
with elevated liver transaminases or signs of biliary
dysfunction such as biliary leak or biliary stricture.2
Most often, however, patients are asymptomatic, and
HAS is identified incidentally on screening Doppler
ultrasound studies. Because of the aggressive nature
of the disease, early identification and screening
is stressed to prevent potentially irreversible liver
damage.1 Waiting for a patient to become symptomatic
can lead to permanent damage to the allograft and is
not the preferred approach. Suspected HAS can be
confirmed on CT angiography or traditional catheterbased angiography.
www.aurora.org/jpcrr
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PTA has been shown to have a technical success rate
of 81–93% in larger HAS trials5 and up to 97–100%
in smaller trials.6 PTA has been shown to decrease
the incidence of hepatic artery thrombosis from
65% to 19%3 in patients presenting with HAS after
transplantation. There is a wide range of variability of
primary patency rates after PTA; and although there
is no uniformly accepted consensus, there is a trend
toward better results with PTA and stenting than with
PTA alone. Hamby et al. reported primary patency
rates of 83%, 74% and 61% at 1, 3 and 6 months,
respectively.6 In addition, recent trials have shown
long-term patency after PTA of 94% at 66 months.7
Patients undergoing primary stenting required fewer
reinterventions than those undergoing PTA alone (31%
vs. 60%). If repeat intervention was necessary, the
mean time to intervention was 62.5 days in the PTAonly group and 236 days in those treated initially with
placement of a stent.6 Saad et al. reported primary
patency rates at 1 year of 44% after angioplasty alone,3
while Chen et al. demonstrated patency rates of 79%
at 1 year.8
A technical issue in endovascular repair, identified in
multiple reports,9 that may affect procedure success
rate and outcome is significant kinking or tortuosity of
the hepatic artery. This is most often related to either
redundancy from a longer vessel or from significant
mismatch in size between donor and recipient arteries.
Kinking and tortuosity can greatly increase the technical
complexity of the procedure by making it difficult to
cross the lesion with a wire or to advance a balloon or
stent. Success rates have been reported as low as 14%
when encountering significant arterial kinks.3 There
is also a trend toward slightly worse patency rates
when encountering significant tortuosity.3,6 Technical
considerations when encountering such anatomy may
include the use of a buddy wire, extra stiff wires or
a device such as the Quick-Cross® support catheter
(Spectranetics Corp., Colorado Springs, CO).3
Utilization of coronary-based techniques for treatment
of hepatic artery stenosis has been widely reported
in the literature.5,6 Vessel diameters are often in the
range of 2.5–5.0 mm, making coronary equipment a
natural choice. Multipurpose coronary guides work
well to engage the celiac artery, and 0.014-inch wires
with excellent maneuverability work well when
130 JPCRR • Volume 2, Issue 3 • Summer 2015

encountering severe stenoses or significant tortuosity.
Coronary stents are very trackable and have good
crossability when encountering these types of lesions.
Hamby’s authorship group reported poor trackability
using self-expanding stents early on in their experience,
leading them to change primarily to the use of coronary
stents unless there was a large mismatch between the
proximal and distal vessel size.6
Our two cases of successful treatment of hepatic and
celiac artery stenosis after liver transplantation reflect
the merits of endovascular approaches. The first
patient demonstrated a more classical presentation
with elevated liver function tests and was found to
have a severe HAS at the anastomotic site. The second
patient was found to have a celiac dissection possibly
related to the transplant surgery or previous catheterbased chemoembolization procedures. Both patients
were successfully treated using traditional coronary
equipment including guides, wires and stents. Drugeluting stents were chosen in both cases based on the
significantly better patency rates demonstrated when
used in the coronary arteries.

CONCLUSIONS

While more data and understanding is needed to guide
therapy and decision-making when encountering
hepatic artery stenosis, our experience has been similar
to past reports in that angioplasty and stenting proved
effective in repairing hepatic and celiac arteries using
coronary techniques and equipment.
Patient-Friendly Recap
• Patients who receive a liver transplant rarely
develop blocked arteries in the abdomen.
• This serious complication may be treated using
endovascular techniques that are less invasive
than open surgery.
• The authors found that hepatic and celiac arteries
could be effectively repaired using coronary
angioplasty and stenting equipment.
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